EU External Trade - Pharmaceutical goods specified in note|4|to this chapter, Gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments

Extra-EU sourcing of Pharmaceutical goods specified in note|4|to this chapter, Gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments is highly concentrated. 🇺🇸 United States captures 40.8% of imports (€68.6M), followed by 🇹🇷 Türkiye (31.5%). With an HHI of 2777, this Concentrated market exposes the EU to supply dependency risks.

The main extra-EU export markets for Pharmaceutical goods specified in note|4|to this chapter, Gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments are 🇺🇸 United States, 🇷🇺 Russia, 🇬🇧 United Kingdom. 🇺🇸 United States absorbs 36.8% of European exports (€164.5M).

Within the EU, the leading importers of Pharmaceutical goods specified in note|4|to this chapter, Gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments are 🇳🇱 Netherlands, 🇮🇹 Italy, 🇩🇪 Germany. 🇳🇱 Netherlands accounts for 21.2% of EU imports.

In 2025, imports were rising (3.6%) and exports surging (109.1%) compared to the previous year.